| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2012108677 |
| Title |
Novel Compound Having Skin-Whitening, Anti-Oxidizing and Ppar Activities and Medical Use Therefor. |
| Abstract |
The present invention relates to a novel compound having skin-whitening, anti-oxidizing and PPAR activities and to a medical use therefor. Compounds according to the present invention can be used to advantage in skin-whitening pharmaceutical compositions or cosmetics as they have a skin-whitening activity whereby tyrosinase is inhibited, and can be used to advantage in the prevention or treatment of skin ageing or the like as they have an anti-oxidizing activity, and can also be used as pharmaceutical compositions or health foods which are useful in preventing and treating obesity, metabolic disease or cardiovascular disease as they have PPAR activity and, more particularly, PPAR and PPAR activity. |
| Applicant(s) |
Pusan Nat University Industry University |
| Representative Drug(s) |
D05AUY |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2009026658 |
| Title |
Ppar Agonists. |
| Abstract |
The present invention relates to PPAR agonists and their use in therapy, including the treatment of disease. In particular, the invention relates to compounds which are PPAR-gamma agonists and/or PPAR alpha/gamma dual agonists. |
| Applicant(s) |
The University of Sydney |
| Representative Drug(s) |
D0O5IN |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2009021467 |
| Title |
Method and Network System of Multimedia Broadcast Multicast Service Transmitting. |
| Abstract |
A transmitting method of multimedia broadcast multicast service is disclosed, including: a main-entity receives MBMS data; the service data is processed by the main-entity via radio link control RLC layer and medium access control MAC layer, the data block processed by MAC layer and air interface sending time sign are sent to an accessory equipment of the main-entity; the data block received in the process adds the air interface sending time sign for forming data packet and sends to a sub-entity; the sub-entity sends the air interface sending time sign and the data block processed by MAC layer to an accessory equipment of the sub-entity; at the air interface sending time, the accessory equipment of the sub-entity and the accessory equipment of the main-entity sends the data block processed by MAC layer. Using the solution of this application, synchronous transmitting of MBMS service is realized. |
| Applicant(s) |
Huawei Technologies Co., Ltd |
| Representative Drug(s) |
D0HW6Y |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2014177593 |
| Title |
Amorfrutin Analogs As Ppargamma-Modulators. |
| Abstract |
The present invention relates to Amorfrutin analogues and stereoisomeric forms, solvates, hydrates, conjugates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these Amorfrutin analogues together with pharmaceutically acceptable carrier, excipient and/or diluents. Said Amorfrutin analogues have been identified as modulators of the peroxisome proliferator-activated receptors (PPARs), especially PPAR and are useful for the prevention and treatment of metabolic diseases, inflammatory diseases, cancer and preparation of phytomedicals and/or functional food products for prevention of metabolic diseases. |
| Applicant(s) |
Boyce Thompson Institute for Plant Research Inc |
